Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David D Kim
Peter J Neumann

Showing results (71-80 of 436) with videos related to

Pageof 44
Sort By:
Health Policy (Amsterdam, Netherlands)|October 10, 2009
Personalized medicine: factors influencing reimbursementLisa M Meckley, Peter J Neumann
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 13, 2012
The economics of mild cognitive impairmentPei-Jung Lin, Peter J Neumann
Expert Review of Pharmacoeconomics & Outcomes Research|June 16, 2010
US healthcare reform: implications for health economics and outcomes researchJames D Chambers, Peter J Neumann
Pharmacoeconomics|August 10, 2017
ICER's Revised Value Assessment Framework for 2017-2019: A CritiquePeter J Neumann, Joshua T Cohen
The New England Journal of Medicine|January 19, 2017
Cost-Effectiveness Analysis 2.0Peter J Neumann, Gillian D Sanders
The American Journal of Managed Care|March 25, 2005
The impact of Medicare modernization on coverage policy: recommendations for reformSusan Bartlett Foote, Peter J Neumann
JAMA|May 26, 2018
QALYs in 2018-Advantages and ConcernsPeter J Neumann, Joshua T Cohen
Health Affairs (Project Hope)|May 9, 2007
What's more dangerous, your aspirin or your car? Thinking rationally about drug risks (and benefits)Joshua T Cohen, Peter J Neumann
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 25, 2012
FDA actions against health economic promotions, 2002-2011Peter J Neumann, Sarah K Bliss
Health Economics|May 16, 2020
Growth and capacity for cost-effectiveness analysis in AfricaAri D Panzer, Joanna G Emerson, Brittany D'Cruz, et al.
Pageof 44

Showing results (71-80 of 436) with videos related to

Sort By:
Pageof 44
Health Policy (Amsterdam, Netherlands)|October 10, 2009
Personalized medicine: factors influencing reimbursementLisa M Meckley, Peter J Neumann
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 13, 2012
The economics of mild cognitive impairmentPei-Jung Lin, Peter J Neumann
Expert Review of Pharmacoeconomics & Outcomes Research|June 16, 2010
US healthcare reform: implications for health economics and outcomes researchJames D Chambers, Peter J Neumann
Pharmacoeconomics|August 10, 2017
ICER's Revised Value Assessment Framework for 2017-2019: A CritiquePeter J Neumann, Joshua T Cohen
The New England Journal of Medicine|January 19, 2017
Cost-Effectiveness Analysis 2.0Peter J Neumann, Gillian D Sanders
The American Journal of Managed Care|March 25, 2005
The impact of Medicare modernization on coverage policy: recommendations for reformSusan Bartlett Foote, Peter J Neumann
JAMA|May 26, 2018
QALYs in 2018-Advantages and ConcernsPeter J Neumann, Joshua T Cohen
Health Affairs (Project Hope)|May 9, 2007
What's more dangerous, your aspirin or your car? Thinking rationally about drug risks (and benefits)Joshua T Cohen, Peter J Neumann
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 25, 2012
FDA actions against health economic promotions, 2002-2011Peter J Neumann, Sarah K Bliss
Health Economics|May 16, 2020
Growth and capacity for cost-effectiveness analysis in AfricaAri D Panzer, Joanna G Emerson, Brittany D'Cruz, et al.
Pageof 44